节点文献

癃开颗粒治疗肾虚瘀阻证型良性前列腺增生症的临床研究

Clinical treatment of the benign prostatic hyperplasia with Longkai Granules

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 谢家骏殷海波贾金铭周智恒许得盛刘树硕乔正东周小初

【Author】 XIE Jia-jun~1,YIN Hai-bo~2,JIA Jin-ming~2,ZHOU Zhi-heng~3,XU De-sheng~4,LIU Shu-shuo~5,QIAO Zheng-dong~1,ZHOU Xiao-chu~1(1.Shanghai Institute of Chinese Materia Medica,Shanghai 201203,China; 2.Guang’anmen Hospital,China Academy of Chinese Medical Scinces,Beijing 100053,China;3.Longhua Hospital Affiliated to Shanghai University of TCM,Shanghai 200032,China;4.Huashan Hospital Affiliated to Fudan University,Shanghai 200040,China;5.The Hospital Affiliated to Zhejiang College of TCM,Hangzhou 310006,China)

【机构】 上海市中药研究所中国中医科学院广安门医院上海中医药大学附属龙华医院复旦大学附属华山医院浙江中医学院附属医院

【摘要】 目的:观察癃开颗粒治疗肾虚瘀阻证型良性前列腺增生症(BPH)的疗效和安全性。方法:遵循随机、双盲双模拟、阳性药物平行对照的原则,将BPH肾虚瘀阻证自愿者485例随机分成治疗和对照组。339例治疗组患者服用癃开颗粒1袋,每日3次,146例对照组患者服用隆必舒胶囊3粒,每日2次,检测和评判连续服用4周的临床疗效。结果:治疗组总有效率79.1%,总显效率42.2%;对照组总有效率60.3%,总显效率为17.1%,差异有显著性(P<0.05);治疗组在改善患者肾虚瘀阻证的主要症状、提高最大尿流率、降低残余尿量、降低I-PSS分值和改善患者生活质量指数等方面,疗效优于对照组(P<0.05)。87例临床控制和显效病例随访3个月,疗效稳定。治疗组连续服用30日,肝、肾功,血、尿常规,血压,心电图,PSA等指标均未见有明显的变化。结论:癃开颗粒对肾虚瘀阻证型BPH具有显著的疗效,且安全无明显毒副反应。

【Abstract】 AIM: To observe the efficacy and safety of Longkai Granule(LKG) in the treatment of benign prostatic hyperplasia(BPH) under ’Kidney-deficiency and blood-stasis syndrome’ in clinic trial. METHODS: According to the principle of the random,double blind,double-simulant and parallel-controlled,485 patients with BPH were randomly divided into two groups.Patients in curative group(n=339) were given orally LKG(1 bag,Tid),and patients in control group(n=146) were given orally Longbishu Capsule(3 granules, Bid) respectively for 4 weeks.And then the international prostatic symptom score(I-PSS),life quality index,prostate volume,maximum flow rate of urine and residual urine in bladder were detected before and after treatment in the two groups.(RESULTS:) The total effective rate and the total significant effective rate were 79.1% and 42.2% respectively in the curative group,while being 60.3% and 17.1% in the control group respectively,in which there was significant difference between the two groups(P<(0.05)).The curative group was notably better than the control group in the aspects of improving the main symptoms of Kidney-deficiency and blood-stasis syndrome,raising maximum flow rate of urine,reducing residual urine volume in bladder and the value of I-PSS in pantients(P<(0.05)).The curative effects were steady in all 87 cases received clinic control and significant effect during the 3 months follow-up.There were no significant differences in the liver and kidney function,blood and urinary routine,blood pressure, electro-Cardio-Gram and prostatic specific antigen in serum after oral administration of LKG for consecutive 30 d.(CONCLUSION:) The therapeutic effect of LKG on BPH is satisfactory with no serious toxicity and side effect.

  • 【文献出处】 中成药 ,Chinese Traditional Patent Medicine , 编辑部邮箱 ,2009年01期
  • 【分类号】R277.5
  • 【被引频次】6
  • 【下载频次】148
节点文献中: 

本文链接的文献网络图示:

本文的引文网络